FuRST 2.0 Cognitive Pre-testing - Round 2
Completed
Conditions studied: Huntington Disease
In brief
The study is a single, cross-sectional cognitive interview of FuRST 2.0, functional rating scale, administered to forty Huntington's Disease Gene Expansion Carriers (HDGECs) and potentially, their companions (the companion's participation is optional in this study). The scale will be tested as a patient reported outcome (PRO) in that the information will come directly from the HDGEC participant or the HDGEC participant together with his/her companion through self-report. The purpose is to identify real or potential comprehension or usage problems with scale items, response options, instructions and disclaimer statement, which are all components of the FuRST 2.0 scale. Through a structured cognitive interview with the HDGEC participants or the HDGEC participants together with their companions, followed by qualitative analysis, the final phrasing of the individual scale items, response options, instructions and disclaimer statement for the scale will be generated. Depending on the results of this study, an additional round of cognitive pre-testing may be required in a separate study.
Key facts
- Study ID
- NCT03709173
- Run by
- CHDI Foundation, Inc.
- People needed
- 52
- Starts
- 2019-08-02
- Expected to finish
- 2019-10-25
- Last updated by the study team
- 2019-10-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Rocky Mountain Movement Disorders Center, P.C. — Englewood, Colorado, United States
- Hereditary Neurological Disease Centre, Inc. — Wichita, Kansas, United States
- Columbia University — New York, New York, United States
- Centre for Movement Disorders (Neuropharm Consulting) — Toronto, Ontario, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.